Supor Nanyang Pharmaceutical is a wholly-owned subsidiary of Supor Group and the core business segment of the Group's layout in the pharmaceutical and health field. Supor Nanyang Pharmaceutical has a complete pharmaceutical industry chain and has built an R&D, production and sales system integrating drug research and development, production and operation. Supor Nanyang Pharmaceutical consists of: three GMP Chinese and Western medicine preparation production bases in Hangzhou, Wuhan and Taizhou, one aerosol research center, and the GSP-certified Zhejiang Supor Pharmaceutical Sales Co., Ltd. In terms of product research and development, Supor Nanyang Pharmaceutical jointly established the * "Pharmaceutical Aerosol Research Center" with the Institute of Cardiovascular Diseases of the China Academy of Chinese Medical Sciences, and hired Academician Chen Keji of the Chinese Academy of Sciences and Professor You Yizhong, the "father of Chinese aerosols", as the company's chief scientists, joining forces to devote themselves to the development of traditional Chinese medicine aerosols. At present, products such as the national Class I new drug "Limonin" have entered the Phase II clinical stage. In terms of pharmaceutical preparations, the preparation segment of Supor Nanyang Pharmaceutical mainly produces Chinese and Western patent medicines, and can simultaneously produce more than ten dosage forms and more than 70 varieties including capsules, tablets and aerosols, among which: 1. Kelisha Capsules, Fuyanling Capsules, Xinnaojian Capsules, etc. have been awarded the titles of "National Traditional Chinese Medicine Protected Variety" and "Chinese Traditional Chinese Medicine Famous Brand Product" respectively; 2. There are seven nationwide exclusive products and exclusively marketed products, namely: Kelisha Capsules, Fuyanling Effervescent Tablets (nationwide exclusive dosage form), Guiyuan Oral Liquid, Bubai Granules, Cordyceps and American Ginseng Capsules, Lactobacillus Dispersible Tablets (nationwide exclusive dosage form), and Kuanxiong Aerosol (nationwide exclusive production and marketing). 3. "Kuanxiong Aerosol" is currently the exclusively produced and sold national medical insurance variety and is the company's key prescription drug flagship product to be built in the future; 4. Nanyang Litong is China's * traditional Chinese medicine external aerosol product. At present, Supor Nanyang Pharmaceutical has launched 7 aerosol and spray products, making it the most * professional aerosol production enterprise in China. In terms of strategic development direction, the company attaches particular importance to the research and development, production and sales of aerosol categories, and has defined its corporate vision as "becoming the * brand and flagship enterprise of pharmaceutical aerosols"; 5. Xinnaojian Capsules are a natural drug extracted from the active ingredients of green tea and are a new generation of cardiovascular therapeutic drugs; Felodipine Tablets and Tinidazole Tablets are nationally insured varieties widely used in clinical practice and supplementary varieties of essential drugs in all provinces across the country. 6. Cordyceps and American Ginseng Capsules are one of the few cordyceps-type medicines in the country. With their excellent quality and definite efficacy, they have won the recognition of elites and become the * of high-end gifts. 7. At the same time, the company has three independent tuberculosis drug production lines and produces anti-tuberculosis drugs in multiple specifications, including compound preparations (FDC) in multiple specifications, and will strive to become one of the * main production bases for anti-tuberculosis drugs in China. In terms of marketing, based on industrial policies, industry development characteristics and product features, the company continuously explores and innovates models and persists in building a more efficient and more professional marketing team. At present, the company has established the Terminal Controlled Sales Division, KA Chain Division, Essential Drug Division, Prescription Recruitment Division, Kuanxiong Aerosol Division,
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows